Text Messaging for Smoking Cessation in College Health Clinics

NCT ID: NCT02191033

Last Updated: 2020-04-01

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-01-31

Study Completion Date

2016-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is a randomized-controlled clinical trial which evaluates the efficacy of physician brief advice, nicotine replacement therapy and a 6-week course of text messaging in promoting cigarette smoking in smokers enrolled in college.

The primary hypothesis is that smokers receiving physician brief advice, nicotine replacement therapy, and text messaging will have higher quit rates that smokers receiving physician brief advice and nicotine replacement therapy alone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cigarette Smoking

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Text messaging

Smoking counseling, nicotine patch, text messaging

Group Type EXPERIMENTAL

Smoking counseling

Intervention Type BEHAVIORAL

Text messaging

Intervention Type BEHAVIORAL

Nicotine patch

Intervention Type DRUG

Standard of care

Smoking counseling, nicotine patch

Group Type ACTIVE_COMPARATOR

Smoking counseling

Intervention Type BEHAVIORAL

Nicotine patch

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Smoking counseling

Intervention Type BEHAVIORAL

Text messaging

Intervention Type BEHAVIORAL

Nicotine patch

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 through 24 years
* Enrolled as a full/part time college student
* A current smoker (Have smoked more than 100 cigarettes in their lifetime and now smoke every day or some days)
* English-speaking
* Interested in quitting
* Have a cell phone for personal use with an unlimited text messaging plan.

Exclusion Criteria

* History of hypersensitivity/allergy to nicotine patch;
* Serious arrhythmias - History of heart disease (myocardial infarction, severe chest pain, or coronary artery disease)
* Current pregnancy/breastfeeding/plan for pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

24 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Southern Connecticut State University

UNKNOWN

Sponsor Role collaborator

University of New Haven

UNKNOWN

Sponsor Role collaborator

Yale University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Deepa R Camenga, MD

Role: PRINCIPAL_INVESTIGATOR

Yale University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Southern Connecticut State University

New Haven, Connecticut, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1404013813

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Quit Smoking Text Message Study
NCT06111755 COMPLETED NA
Penn State TXT2Quit Study
NCT02367391 COMPLETED NA